Thursday, February 9, 2012

FDA investigates Xenical, Alli over reports of liver damage

(HealthScout) UPDATED 2009-08-25
As U.S. health officials announced Monday that they are investigating the weight-loss drug orlistat for possible incidents of liver damage, experts noted the drug might not even work well enough to warrant such potential risks.  Read full story >
See all Obesity News